Dear colleagues and partners,
We are writing to anticipate your formal invitation to the Eliminate Yellow fever Epidemics (EYE) Strategy Annual Partners’ Meeting, from the 19th to 21st March 2024 in Addis Ababa, Ethiopia, pending final approval from the Government of Ethiopia. Further details on venue and accommodation to follow.
We are keen for as many people to join us in person as possible. This will be our first occasion to do so since the 2019 Annual Partners’ Meeting, and there will be many opportunities for in-person discussions and networking during our time together.
Unless previously notified, travel cost and other expenses will not be covered by the Secretariat. You will be provided with a formal invitation once the location of the meeting is confirmed. We urge you NOT TO BOOK ANY TRAVEL until we confirm that you can go ahead.
To help us with our planning, we would like to understand how many people will be attending the event – either in person or online (the meeting will be live streamed) – so please complete the following link to register no later than 15th February 2024: https://indico.un.org/event/1009573/
Should you have any questions or encounter any difficulties during the registration process, please contact Ilhem Abassi on This email address is being protected from spambots. You need JavaScript enabled to view it.. For any other meeting-related questions, please contact Rakhee Verma on This email address is being protected from spambots. You need JavaScript enabled to view it..
We are in the accelerated phase of the EYE Strategy, which ends in 2026. This means we have a limited amount of time to amplify our activities, reach our goals and protect almost 1 billion people against yellow fever for life. This meeting is key to our ongoing success.
An agenda and further information will follow shortly. We are excited to see you in March, and thank you for your ongoing engagement in the EYE Strategy.
Best wishes from Dr Laurence Cibrelus and the EYE Secretariat.
Together. In our lifetime. We will eliminate yellow fever epidemics.
